FDA Warns of False Positives for Zika Test

Dec 23, 2016

NEW YORK (360Dx) – The US Food and Drug Administration said today that Laboratory Corporation of America reported false-positive results using the first commercially available Zika serological IgM test, which is manufactured by InBios International.

As a result, the FDA issued recommendations to physicians using the test not to depend solely on it to diagnose patients.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Menu

FDA Warns of False Positives for Zika Test

To read the full story....

Breaking News

At ESHG, Researchers Present New Noninvasive Prenatal Tests, Disease Recurrence Risk Study

USPTO Denies Foundation Medicine Attempt to Invalidate Guardant Health Patent

In Brief This Week: SpeeDx, Abbott

Bio-Techne Gets New York State Approval for Prostate Cancer Test

FDA Issues Draft Recommendations For Biotin Interference Testing

FDA Clears Roche Extraction Platform For Use With Applied BioCode GI Pathogen Panel, System

Error-Corrected Sequencing to Detect Measurable Residual Disease in Post-Transplant MDS Cases

What's Popular?

FDA Issues Draft Recommendations For Biotin Interference Testing

Fujifilm, FIND Developing Urine-Based, Point-of-Care TB Test With Higher Accuracy

FDA Clears Roche Extraction Platform For Use With Applied BioCode GI Pathogen Panel, System

Metagenomic CSF Sequencing Improves Diagnosis of Neurological Infections, UCSF Study Finds

Siemens Healthineers, Roche Diagnostics, PerkinElmer, Others Receive FDA Nods in May

Sponsorships